|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term investments | |||||||||
| Accounts receivable, net of allowance for credit losses of $1,526 and $1,168 respectively | |||||||||
| Related party receivables | |||||||||
| Related party loans receivables | |||||||||
| Prepaid taxes | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Non-current assets: | |||||||||
| Property and equipment, net | |||||||||
| Goodwill | |||||||||
| Intangible assets, net | |||||||||
| Operating lease right-of-use assets | |||||||||
| Deferred tax assets | |||||||||
| Other non-current assets | |||||||||
| Total non-current assets | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders’ Equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Related party payables | |||||||||
| Contract liabilities | |||||||||
| Operating lease liabilities | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Accrued compensation expenses | |||||||||
| Income taxes payable | |||||||||
| Related party short-term debt | |||||||||
| Convertible debt | |||||||||
| Contingent consideration | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities: | |||||||||
| Operating lease liabilities | |||||||||
| Other liabilities | |||||||||
| Related party revolving line of credit | |||||||||
| Related party long-term debt | |||||||||
| Deferred tax liabilities | |||||||||
| Contingent consideration | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders’ equity: | |||||||||
| Net Parent investment (deficit) | |||||||||
| Common stock,$0.001 par value; 250,000,000 shares authorized; 72,830,090 shares issued and 72,792,606 shares outstanding at September 30, 2026; 72,308,235 shares issued and 72,291,454 shares outstanding at December 31, 2025 | |||||||||
| Stockholder receivable | |||||||||
| Additional paid-in-capital | |||||||||
| Treasury stock, at cost; 37,484 and 16,781 shares at September 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Accumulated other comprehensive income | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...